Modified histologic grading of neuroblastomas by replacement of mitotic rate with Mitosis Karyorrhexis Index: A clinicopathologic study of 223 cases from the Pediatric Oncology Group
Authors:
Open Access
Abstract
BACKGROUND Histologic grading (HG) of neuroblastomas (NB) of prognostic significance is based on the presence or absence of calcification and low mitotic rate (≤10/10 high power fields). Mitosis Karyorrhexis Index (MKI) is the main feature used for prognostic categorization in Shimada classification and can be determined more readily than mitotic rate (MR). The purpose of this study is to test whether MKI can be used instead of MR for histologic grading. METHODS Low and intermediate MKI were lumped together as low MKI. We replaced MR with the modified MKI categories. The histologic grades for 223 NBs registered with the Pediatric Oncology Group protocols 8104 and 8441, were defined as follows: HG 1 = calcification + low MKI, HG 2 = calcification or low MKI, HG 3 = high MKI and absence of calcification. Shimada classification was also determined for comparison of modified HGs with favorable histology (FH) and unfavorable histology (UH), HGs were linked with age: low risk (LR) = HG 1 in all age groups + HG 2 in patients age younger than 1 year; high risk (HR) = HG 2 in patients age 1 year or older + HG 3 in all age groups. RESULTS Statistically significant differences in 5‐year survival were seen in the NBs of different modified HG (1: 92.7%, 2: 74.9%, and 3: 18.2%) and risk groups (LR: 93.0% and HR: 47.9%) (P < 0.0001 and P = 0.0001, respectively). CONCLUSIONS Pathologists may readily adapt to the modified HG described here. Advantages of modified HGs include: (1) familiarity and reproducibility of MKI; (2) no need for linkage with age; and (3) a combination of features used in original HGs and Shimada classification. Cancer 1996; 77:1582‐8.Keywords
This publication has 11 references indexed in Scilit:
- Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc AnalysisJNCI: Journal of the National Cancer Institute, 1995
- Correlation between morphologic and other prognostic markers of neuroblastoma a study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the pediatric oncology groupCancer, 1993
- Function of the c‐Myc oncoproteinThe FASEB Journal, 1992
- Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the pediatric oncology groupCancer, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study GroupHuman Pathology, 1988
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI: Journal of the National Cancer Institute, 1984
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- Wilms' tumor and other renal tumors of childhood: A selective review from the National Wilms' Tumor Study Pathology CenterHuman Pathology, 1983
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977